BioMarin

YTD

ALL

Trade BioMarin 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO

Alexander Hardy

CEOAlexander Hardy

Employees

3,040

Employees3,040

Headquarters

San Rafael, California

HeadquartersSan Rafael, California

Founded

1997

Founded1997

Employees

3,040

Employees3,040

BMRN Key Statistics

Market cap

11.22B

Market cap11.22B

Price-Earnings ratio

17.20

Price-Earnings ratio17.20

Dividend yield

—

Dividend yield—

Average volume

2.02M

Average volume2.02M

High today

$58.85

High today$58.85

Low today

$57.74

Low today$57.74

Open price

$58.23

Open price$58.23

Volume

1.03M

Volume1.03M

52 Week high

$93.04

52 Week high$93.04

52 Week low

$52.93

52 Week low$52.93

BMRN News

Simply Wall St 1d

Will BioMarin’s Finance Team Transition Shape Investor Views on Rare Disease Innovation?

On August 5, 2025, BioMarin Pharmaceutical announced the voluntary resignation of Erin Burkhart, its Group Vice President, Chief Accounting Officer, and princip...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.